Robert D. Millham
2017
In 2017, Robert D. Millham earned a total compensation of $3.4M as Former Chief Operating Officer at Odonate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $3,022,231 |
| Salary | $168,182 |
| Other | $5,045 |
| Total | $3,395,458 |
Millham received $3M in option awards, accounting for 89% of the total pay in 2017.
Millham also received $200K in non-equity incentive plan, $168.2K in salary and $5K in other compensation.
Rankings
In 2017, Robert D. Millham's compensation ranked 3,119th out of 14,666 executives tracked by ExecPay. In other words, Millham earned more than 78.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,119 out of 14,666 | 79th |
Division Manufacturing | 1,074 out of 5,772 | 81st |
Major group Chemicals And Allied Products | 293 out of 2,075 | 86th |
Industry group Drugs | 224 out of 1,731 | 87th |
Industry Pharmaceutical Preparations | 178 out of 1,333 | 87th |
Source: SEC filing on June 1, 2018.
Millham's colleagues
We found two more compensation records of executives who worked with Robert D. Millham at Odonate Therapeutics in 2017.